AzTrials
AzTrials

Length of StayNCT07726108

Digital Anticipatory Protocols at Triage to Improve ED Flow.

An observational study of Length of Stay and Emergency Department Crowding, run by Hôpital Fribourgeois at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate a pre-post intervention adding an early management decision at the end of the triage process to improve patient throughput. The intervention consists of adding digital checkboxes to the electronic triage system, providing nurses with formalized options for anticipated management based on… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Digital Anticipatory Protocols at Triage
Type of treatment
Surgery or procedure
How many people
15,500 participants
Where
1 siteSwitzerland
Study dates
1 May 2026to 31 Aug 2027
How long will I take part?
30 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population comprises all adult patients (over 18 years old) presenting to the emergency department of the cantonal hospital in Fribourg (HFR), Switzerland, during the predefined study periods (Phase 1 and Phase 2). The HFR is a university teaching and research hospital that manages approximately 41,000 ED visits annually.

Who may be able to join

  • All patients over 18 years who registered at the admission desk during the study period.

Who cannot join

  • Arrival by emergency medical services (ambulance or helicopter)
  • Patient trajectory bypassing the standard nurse-led triage process
  • Patient directly referred to another service of the hospital after triage (gynecology, ophthalmology, etc.).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Switzerland1 site, 1 recruiting
  • Fribourg Cantonal Hospital

    Villars-sur-Glâne, Canton of Fribourg, 1752

    Thomas Castelain, +41263061392, thomas.castelain@h-fr.ch

    Youcef Guechi, youcef.guechi@h-fr.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Implementing Digital Anticipatory Protocols at Triage to Improve Emergency Department Flow: A Before-After Study Protocol

This study aims to evaluate a pre-post intervention adding an early management decision at the end of the triage process to improve patient throughput. The intervention consists of adding digital checkboxes to the electronic triage system, providing nurses with formalized options for anticipated management based on patient acuity. The study compares a pre-intervention phase (May 1st to July 31st, 2026) with a post-intervention phase (May 1st to July 31st, 2027) to naturalize seasonal confounders. The primary outcome is the total Emergency Department Length of Stay (ED LOS).

Being tested
Digital Anticipatory Protocols at Triage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital Anticipatory Protocols at TriageProcedure or surgery

    The intervention consists of adding digital checkboxes to the electronic triage system. This provides nurses with formalized options for anticipated management based on patient acuity, aiming to encourage and document anticipatory actions while stimulating clinical reasoning.

Study groups in NCT07726108
Study groupRoleWhat they receive
Phase 1 - Pre-interventionPatients presenting to the emergency department between May 1st and July 31st, 2026. Patients undergo standard triage assessment performed using the revised Swiss Emergency Triage Scale (SETS). Disposition decisions are monitored using a digital tag in the electronic health records.
Phase 2 - Post-interventionPatients presenting to the emergency department between May 1st and July 31st, 2027. Patients undergo triage with the addition of a new digital anticipatory protocol. Disposition decisions continue to be monitored using the same digital tag.
Receives: Procedure: Digital Anticipatory Protocols at Triage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Emergency Department Length of Stay (ED LOS).

    The time interval from the completion of the patient's administrative registration to their physical departure from the ED

    Measured: Through completion of the ED visit, up to a maximum of 72 hours.

Secondary outcomes (3)
  1. Left without being seen (LWBS)

    Proportion of patients who registered at the ED admission desk and left before receiving a medical screening exam or an evaluation by a physician

    Measured: Through completion of the ED visit, up to a maximum of 72 hours.

  2. 30-day mortality

    Assessed through institutional medical records to evaluate safety

    Measured: Up to 30 days post-ED visit

  3. Intesive Care Unit (ICU) transfers

    Proportion of patients transferred to the Intensive Care Unit (ICU) immediately and within 7 days after the ED visit

    Measured: Up to 7 days post-ED visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2026
  2. Study start1 May 2026
  3. Primary completion31 Jul 2027 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
15,500 participants (estimated)
Target duration
30 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07726108
Sponsor's protocol ID
Req-2026-00230
Status last verified
Jul 2026
First submitted
14 Jul 2026
Last updated
24 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Data sharing is restricted by the Swiss Human Research Act and local ethics committee (Swissethics) due to the retrospective/observational nature of this quality improvement project and the lack of explicit patient consent for public open-data sharing.

Questions about this trial

What is this clinical trial studying?

An observational study of Length of Stay and Emergency Department Crowding, run by Hôpital Fribourgeois at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Thomas Castelain (+41263061392, thomas.castelain@h-fr.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Emergency Department Length of Stay (ED LOS). (time frame: Through completion of the ED visit, up to a maximum of 72 hours.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in